Open AccessLong-term outcome of tumor necrosis factor alpha antagonist's treatment in pediatric Crohn's disease
Author(s) -
Amit Assa,
Corina Hartman,
Batia Weiss,
Efrat Broide,
Yoram Rosenbach,
Noam Zevit,
Yoram Bujanover,
Raanan Shamir
Publication year - 2012
Publication title -
journal of crohn s and colitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.277
H-Index - 80
eISSN - 1876-4479
pISSN - 1873-9946
DOI - 10.1016/j.crohns.2012.03.006
Subject(s) - crohn's disease , medicine , tumor necrosis factor alpha , antagonist , disease , term (time) , tumor necrosis factor α , gastroenterology , receptor , physics , quantum mechanics
Anti tumor necrosis factor alpha (TNFα) agents have become widely used in pediatric inflammatory bowel disease (IBD). So far, only few studies examined the long-term results of anti-TNFα treatment in children with IBD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom